Section 10.1
Principles of Anti-Infective Therapy
Explain how suspected infection, evidence, targeted exposure and safety review form one anti-infective decision loop.
Learn
Idea 1 / 3
Syndrome before certainty
An infection occurs when a microorganism invades and harms the body. A syndrome is a pattern of findings, such as cough, fever and breathing difficulty; it does not identify one particular germ. A clinician combines examination, severity, previous medicines and useful samples. A culture is a laboratory attempt to grow and identify an organism. Empiric treatment begins before the exact organism is known, using the most likely causes and the urgency of illness. It must be reconsidered as evidence improves.
In shock, sampling and urgent treatment may proceed together; in a stable patient, a reliable culture may guide a narrower choice.
Read all essential notes
Syndrome before certainty
An infection occurs when a microorganism invades and harms the body. A syndrome is a pattern of findings, such as cough, fever and breathing difficulty; it does not identify one particular germ. A clinician combines examination, severity, previous medicines and useful samples. A culture is a laboratory attempt to grow and identify an organism. Empiric treatment begins before the exact organism is known, using the most likely causes and the urgency of illness. It must be reconsidered as evidence improves.
In shock, sampling and urgent treatment may proceed together; in a stable patient, a reliable culture may guide a narrower choice.
Spectrum is a match
A medicine’s spectrum is the range of microorganisms it can affect. Broad coverage may be useful while a serious infection is being investigated, but broader does not automatically mean better. The microbiome is the community of microbes normally living in and on us; unnecessary treatment can disturb it. Selection pressure means that susceptible microbes are removed while resistant ones are more likely to survive. Once the cause is known, a narrower effective medicine can reduce unnecessary exposure if it reaches the infection site and suits the patient.
Improvement does not prove that every organism covered initially was present or that the broadest option is safest.
Exposure and host safety
Activity in a laboratory is only one requirement. A medicine must also reach the infected tissue in an effective amount, called adequate exposure. Clearance means removal of medicine from the body; reduced kidney or liver function can increase exposure for some drugs and raise toxicity risk. Allergy history, pregnancy, immune function and other medicines also matter. Monitoring means checking the response and possible harm over time. These checks guide professional treatment decisions; they are not a formula for selecting a dose from a single symptom.
A medication history may reveal a serious interaction before the first dose; organ review may require a locally approved adjustment or closer follow-up.
Common misconception: “Broadest” does not mean “strongest”; activity, site exposure and host safety must all fit.
Explore
Follow the mechanism. Select a step to explain what changes and why. This is a schematic, not a physiological simulation.
Step 1 / 3
Assess
Recognize urgency, likely source and host risks; obtain a useful specimen when this will not delay life-saving care.
Go deeper: worked example
A 68-year-old patient has fever, cough and low blood pressure. A blood culture is collected before urgent empiric therapy. Two days later, the organism is identified and susceptible to a narrower medicine; kidney function is less stable.
- First identify urgency. Low blood pressure with suspected serious infection may require prompt treatment. A useful specimen helps later decisions, but obtaining it must not create an unsafe delay in life-saving care.
- Next distinguish the initial guess from the new evidence. Empiric coverage was based on plausible causes. The culture now identifies a susceptible organism, allowing the team to compare specific options rather than simply repeat the original plan.
- Then check what the laboratory result cannot establish by itself. A narrower drug must reach the infected tissue, suit the person’s allergy history and have an acceptable interaction profile. Unstable kidney function requires a fresh review of exposure and safety.
- Finally compare the choices using both benefit and avoidable harm. If the narrower option fits these conditions, continued broad coverage needs a specific justification. The clinical team also reviews duration and response rather than assuming that initial improvement ends the need for monitoring.
Safe treatment is a loop integrating urgency, evidence, response and host safety.
Explain it yourself
Why can improvement justify reassessment?
Reveal explanation
Improvement suggests benefit but does not identify the organism or prove broad exposure remains necessary or safe.
Create and evaluate
Draw the decision loop and add one evidence and one safety checkpoint at each stage.
Formative activity: compare your reasoning with the rubric. This response is not automatically graded and does not award mastery. It remains only on this page and is cleared when you leave.
Compare with the rubric and example
- Links syndrome, specimen, coverage and reassessment.
- Explains why narrowing or stopping may help.
- Names a host-specific safety check and reason.
The map shows urgent assessment, deliberate empiric coverage, evidence review, and a continue/narrow/change/stop decision with monitoring.
Sources and review status
Educational draft. Medical and French-language expert review pending. External sources require an internet connection; essential explanations are included above.
- Clinical Pharmacology Made Incredibly Easy!, 3rd ed. (2009)
Chapter 10, printed pp. 237–292; PDF page = printed page + 12
- WHO: Antimicrobial resistance
Resistance drivers and stewardship, accessed 2026-09-21
- CDC: Core Elements of Hospital Antibiotic Stewardship Programs
Hospital stewardship actions, accessed 2026-09-21
Check my understanding
Mastery Question Gate
Answer all questions correctly to unlock the next lesson. Retakes vary the selection when enough questions are available; some questions may repeat.
1. Why is trough serum level monitoring critical during vancomycin therapy?